Biotech · Private company
Endocyte
Track this companyFree. Adds Endocyte to your Dealase workspace and tells you when its record changes.
Clinical trials120 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- 177Lu-PSMA-617Phase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- 177Lu-PSMA-617Phase 2 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EC145Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Tc 99m EC20Phase 2 · Metastatic Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Technetium Tc 99m EC20Phase 2 · Metastatic Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Technetium Tc 99m EC20Phase 2 · Pituitary TumorsClinicalTrials.gov · fetched Nov 12, 2026
- 99mTc-EtarfolatidePhase 1 · Ovary CancerClinicalTrials.gov · fetched Nov 12, 2026
- EC0652Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EC1169Phase 1 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EC1456Phase 1 · Ovary CancerClinicalTrials.gov · fetched Nov 12, 2026
- EC1456 and EC20Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Tc 99m EC20Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- indium In 111 folic acidOvarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- radionuclide imagingOvarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerPHASE3 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03511664 · fetched Nov 12, 2026
- Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapyPHASE2 · TERMINATED · started Jul 12, 2017ClinicalTrials.gov NCT03042312 · fetched Nov 12, 2026
- An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing SurgeryPHASE1 · COMPLETED · started Jan 24, 2017ClinicalTrials.gov NCT03011320 · fetched Nov 12, 2026
- Phase 1 of EC1169 In Patients With Recurrent MCRPCPHASE1 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02202447 · fetched Nov 12, 2026
- Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01999738 · fetched Nov 12, 2026
- Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)PHASE2 · COMPLETED · started Dec 31, 2009ClinicalTrials.gov NCT01002924 · fetched Nov 12, 2026
- Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell CarcinomaPHASE2 · COMPLETED · started Nov 1, 2003ClinicalTrials.gov NCT01689766 · fetched Nov 12, 2026
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary TumorsPHASE2 · COMPLETED · started Sep 1, 2002ClinicalTrials.gov NCT01689727 · fetched Nov 12, 2026
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell CarcinomaPHASE2 · COMPLETED · started Aug 1, 2002ClinicalTrials.gov NCT01689662 · fetched Nov 12, 2026
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerPHASE1 · COMPLETED · started Aug 1, 2001ClinicalTrials.gov NCT01686256 · fetched Nov 12, 2026
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsPHASE1 · COMPLETED · started Aug 1, 2000ClinicalTrials.gov NCT01689636 · fetched Nov 12, 2026
- Radiolabeled Folic Acid and Imaging to Detect Ovarian CancerNA · COMPLETED · started Dec 8, 1997ClinicalTrials.gov NCT00003763 · fetched Nov 12, 2026